Second positive Phase 3 Dupixent® (dupilumab) trial confirms significant improvements for patients with prurigo nodularis

Pat Purcell
Meeting Engagement

Thomas Shea
Programmatic Marketing

Daniel Sontupe
Market Access

Anil Bhaskar
Unified Customer Experience

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement

David Linetsky
Patient Activation

Stacey Gandler
Brand Nourishment

Laura Blair
Medication Adherence

Mike Viscel
Increasing Engagement

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Frank Burrell
Scientific Storytelling

Frank X. Powers
Healthcare Challenger Brands

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability

Liz Kane
Impactful Strategy